Our global financial, industrial, and scientific experience enables us to deliver high-quality management consulting and advisory services, including:
- due diligence of pharmaceutical products, portfolios and companies;
- assessment of competitive environment and development/market risks;
- development of clinical strategy for pharmaceutical products;
- identifying attractive targets for in-licensing or acquisition;
- transaction and scientific advisory support for in-licensing, technology transfer and support of R&D/commercialization in Russia for foreign companies;
- development of R&D and marketing strategy of Russian products in US and EU.
Our broad network of KOLs in diverse therapeutic areas brings unmatched potential to our diligence efforts.
The team’s successful track record of pharmaceutical development from raw idea to the market is the strongest evidence of our expertise.